Article thumbnail

Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer

By Cong-Xiang Shen, Zhong Wen, Yu-Hong Qian, Shao-Feng Mu and Xiao-Fang Guan
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2008). Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao
  2. (2005). An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells.
  3. (2000). BL: Down-regulation of telomerase and its RNA and apoptosis in HNE1 celllines of nasopharyngeal carcinama induced by hTR antisense oligonucleotide.
  4. (2009). CX: TK gene targeted therapy mediated by the human telomerase promoter in nude mouse transplanted tumor of nasophyngeal carcinoma in vivo. Jie Fang Jun Yi Xue Za Zhi
  5. (2008). DX: An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter. Sichuan Da Xue Xue Bao Yi Xue Ban
  6. (2006). et al: In vitro research of enhanced suicide gene vector for cervix cancer therapy. China Medical Engineering
  7. (2006). et al: Incorporation of prokaryotic enhancer for enhancement of gene expression driven by hTERT promoter.
  8. (2002). Fang B: hTERT promoter induces tumorspecific Bax gene expression and cell killing insyngenic mouse tumor model and prevents systemic toxicity. Gene Ther
  9. (2004). Fang B: Suppressing orthotopic pancreatic tumor growth with a fiber modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter. Clin Cancer Res
  10. (2009). FC: Radiosensitization and anti-tumour effects of cytosine deaminase and thymidine kinase fusion suicide gene in human adenoid cystic carcinoma cells.
  11. (2003). Hashizume K: Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter. JCEM
  12. (2008). hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells. Cancer Biol Ther
  13. (2007). KT: Identification of label-retaining cells in nasopharyngeal epithelia and nasopharyngeal carcinoma tissues. Histochem Cell Biol
  14. (2009). KT: Screening and preliminary analysis of the apoptosis- and proliferation-related genes in nasopharyngeal carcinoma. Nan Fang Yi Ke Da Xue Xue Bao
  15. (2008). Liang GP: Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
  16. (2008). MH: Isolation and identification of tumor-like stem cells from human nasopharyngeal carcinoma cell line. Jie Fang Jun Yi Xue Za Zhi
  17. (2010). Potent anti-tumor activity of telomerase-dependent and HSV-1TK armed oncolytic adenovirus for non-small cell lung cancer in vitro and in vivo.
  18. (2009). Prostate tumor-initiating cells: A new target for telomerase inhibition therapy? Biochim Biophys Acta
  19. (2002). S: Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells. Hum Gene Ther
  20. (2007). SH: Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res
  21. (2009). Sleeping Beauty-mediated suicide gene therapy of hepatocellular carcinoma.
  22. (2004). Suppression of Epstein-Barr virusencoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cell. Biochem Biophys Res Commun
  23. (2008). Tao Z: The effect of shRNA targeting hTERT on telomerase and the expression of PCNA and Caspase-3 in nasopharyngeal carcinoma cells.
  24. (2000). The expression of telomerase and telomerase RNA in nasopharyngeal carcinoma (NPC) and HNE1 cell lines of NPC.
  25. (1998). Tsao SW: Telomerase activation in nasopharyngeal carcinomas.
  26. (2010). Xiao JY: Tumor-specific TK gene therapy induced by hTERT promoter in human nasopharyngeal carcinoma (NPC) cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao
  27. (2003). YT: Adenovirus-mediated suicide gene therapy using the human telomerase catalyticsubunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line. Biosci Biotechnol Biochem
  28. (2009). Zhang QW: Combination effect of oncolytic adenovirus therapy and herpes simplex virus Shen et al.
  29. (2008). Zhou YF: Radio-activation of hTERT promoter in larynx squamous carcinoma cells: an ‘indirected-activator’ strategy in radio-gene-therapy. Oncol Rep